StevenLeeAllenMD

Clotting Disorder, Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell

Dr. Allen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
450 Lakeville Rd
# The
Lake Success, NY 11042
Phone+1 516-734-8959

Fax+1 516-734-8863

Steven Allen, MD, is a hematologist based in Lake Success, NY, specializing in clotting disorders, hematologic oncology, and myeloproliferative disorders. He earned his M.D. from Johns Hopkins University School of Medicine in 1977 and completed his fellowship in hematology and medical oncology at New York Presbyterian Hospital (Cornell Campus). Dr. Allen holds leadership roles as Associate Chief of the Division of Hematology and System Head of Benign Hematology at Northwell Health. His professional experience includes work with benign hematology, hematologic oncology, myelodysplasia, and myelofibrosis. Dr. Allen has published extensively, including recent works in journals such as Leukemia and Blood. His achievements in medicine have been recognized with honors such as being named a Super Doctor and a Top MD.

New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1980 - 1983
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1978 - 1980
New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 1977 - 1978
Johns Hopkins University School of MedicineClass of 1977, M.D.

PubMed

CLL crosstalk with naïve T cells enhances the differentiation of IL-22-producing T cells and CLL -cell survival.
Gerardo Ferrer, Florencia Palacios, Pui Yan Chiu, Kelly Wong, Alberto Bueno-Costa
Leukemia. 2025-02-01
Less is more: An analysis of venetoclax and hypomethylating agent post-induction treatment modifications in AML.
Stephanie Boisclair, Edward Zhou, Phyu Naing, Richa Thakur, Erin Jou
Leukemia Research. 2024-08-01
Dialysis Patient With a Unique Rash.
Alissa Cyriac, Steven L Allen, Sophia Cyriac, Kenar D Jhaveri
Kidney Medicine. 2024-07-01

Abstracts/Posters

CLL B Cells Develop Resistance to Ibrutinib By Reinvigorating the IL-4R - IL-4 Axis Blocked By BrutonÍs Tyrosine Kinase Inhibitors Including Acalabrutinib and Zanubrut...
Steven L. Allen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Singing the Blues for Blue Top TubesJuly 20th, 2021
Systems-Based Hematology Success Stories Investment Will Bolster Growing SubspecialtyDecember 1st, 2020